SCHEMBL1011168

SCHEMBL1011168

Clc1ccccc1[S+](c1ccccc1Cl)c1ccccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
LMNA P02545 1/20 0.56
ALDH1A1 P00352 3/20 0.43
CYP2A6 P11509 4/20 0.40
CYP1A2 P05177 3/20 0.40
IDO1 P14902 3/20 0.39
POLB P06746 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
PNMT P11086 1/20 0.38
TAAR1 Q96RJ0 1/20 0.35
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31005108 1.00 TSHR (0.56) TSHRLMNAALDH1A1CYP2A6CYP1A2
SCHEMBL3201226 0.83 TSHR (0.45) TSHRLMNAALDH1A1CYP2A6CYP1A2
SCHEMBL31005119 0.83 TSHR (0.45) TSHRLMNAALDH1A1CYP2A6CYP1A2
SCHEMBL31005101 0.83 TSHR (0.45) TSHRLMNAALDH1A1CYP2A6CYP1A2
SCHEMBL2222737 0.83 TSHR (0.45) TSHRLMNAALDH1A1CYP2A6CYP1A2
Acetic Acid SCHEMBL11136830 0.81 POLB (0.42) TSHRLMNAALDH1A1POLBCES2
SCHEMBL5085586 0.75 TSHR (0.50) TSHRLMNAALDH1A1CYP2A6CYP1A2
1,2-Dichlorobenzene SCHEMBL5190 0.73
1,2-Dichlorobenzene SCHEMBL10593125 0.73
1,2-Dichlorobenzene SCHEMBL1155123 0.73 TSHR (1.00) TSHRLMNAALDH1A1CYP2A6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180011401-A1 SULFONIC ACID DERIVATIVE, PHOTOACID GENERATOR USING SAME, RESIST COMPOSITION, AND DEVICE MANUFACTURING METHOD TOYO GOSEI CO., LTD. (JP) 2018-01-11 US disclosed
US-9714217-B2 Sulfonic acid derivative and photoacid generator TOYO GOSEI CO., LTD. (JP) 2017-07-25 US disclosed
EP-2065449-B1 Ink composition for inkjet recording, inkjet recording method, and printed material FUJIFILM CORP (JP) 2016-01-06 EP disclosed
EP-2105480-B1 Ink composition, ink for inkjet recording and ink set using the ink FUJIFILM CORP (JP) 2014-12-10 EP disclosed
EP-2570853-B1 Oxygen-blocking film and lithographic printing plate precursor comprising said film FUJIFILM CORP (JP) 2014-08-20 EP disclosed
US-8710123-B2 Ink composition, ink for inkjet recording and ink set using the ink FUJIFILM CORPORATION (JP) 2014-04-29 US disclosed
US-20130130175-A1 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method CENTRAL GLASS COMPANY, LIMITED (JP) 2013-05-23 US disclosed
US-8435717-B2 Compound for photoacid generator, resist composition using the same, and pattern-forming method CENTRAL GLASS COMPANY, LIMITED (JP) 2013-05-07 US disclosed
US-20130071786-A1 COATING COMPOSITION AND IMAGE-FORMING MATERIAL, LITHOGRAPHIC PRINTING PLATE PRECURSOR AND OXYGEN-BLOCKING FILM INCLUDING THE COATING COMPOSITION FUJIFILM CORPORATION (JP) 2013-03-21 US disclosed
EP-2570853-A2 Coating composition and image-forming material, lithographic printing plate precursor and oxygen-blocking film including the coating composition Fujifilm Corporation (JP) 2013-03-20 EP disclosed
EP-2065449-A2 Ink composition for inkjet recording, inkjet recording method, and printed material FUJIFILM Corporation (JP) 2009-06-03 EP disclosed
US-20090088491-A1 PHOTO-CURABLE COMPOSITION INCLUDING POLYMERIZABLE COMPOUND, POLYMERIZATION INITIATOR, AND DYE FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
EP-2042570-A1 Photo-curable composition including polymerizable compound, polymerization initiator, and dye FUJIFILM Corporation (JP) 2009-04-01 EP disclosed
EP-1757635-B1 Curable ink comprising modified oxetane compound FUJIFILM CORP (JP) 2008-10-08 EP disclosed
US-7414148-B2 Process for producing alkoxycarbonylfluoroalkanesulfonates CENTRAL GLASS COMPANY LIMITED (JP) 2008-08-19 US disclosed
US-20080108846-A1 PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES CENTRAL GLASS COMPANY, LIMITED (JP) 2008-05-08 US disclosed
US-20070112088-A1 Curable composition, ink composition, inkjet recording method, printer matter, method for producing planographic printing plate, planographic printing plate and oxetane compound FUJIFILM CORPORATION 2007-05-17 US disclosed
EP-1783184-A1 Curable ink composition and oxetane compound Fujifilm Corporation (JP) 2007-05-09 EP disclosed
US-20070049651-A1 Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, planographic printing plate, and oxcetane compound FUJI PHOTO FILM CO., LTD. 2007-03-01 US disclosed
EP-1757635-A1 Curable modified oxetane compound and ink composition comprising it Fuji Photo Film Co., Ltd. (JP) 2007-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180011401-A1 SULFONIC ACID DERIVATIVE, PHOTOACID GENERATOR USING SAME, RESIST COMPOSITION, AND DEVICE MANUFACTURING METHOD ASIC1, ASIC3, CRY1 TSHR 2626/4885LMNA 4638/4885ALDH1A1 565/4885
US-20080108846-A1 PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES ARSA, PFAS, MPST TSHR 3426/4885LMNA 4520/4885ALDH1A1 713/4885
US-20130130175-A1 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method ASIC1, RER1, INSRR TSHR 988/4885LMNA 4640/4885ALDH1A1 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.